Abstract:While many disease-associated single nucleotide polymorphisms (SNPs) are associated with gene expression (expression quantitative trait loci, eQTLs), a large proportion of complex disease genome-wide association study (GWAS) variants are of unknown function. Some of these SNPs may contribute to disease by regulating gene splicing. Here, we investigate whether SNPs that are associated with alternative splicing (splice QTL or sQTL) can identify novel functions for existing GWAS variants or suggest new associated variants in chronic obstructive pulmonary disease (COPD). RNA sequencing was performed on whole blood from 376 subjects from the COPDGene Study. Using linear models, we identified 561,060 unique sQTL SNPs associated with 30,333 splice sites corresponding to 6,419 unique genes. Similarly, 708,928 unique eQTL SNPs involving 15,913 genes were detected at 10% FDR. While there is overlap between sQTLs and eQTLs, 55.3% of sQTLs are not eQTLs. Co-localization analysis revealed that 7 out of 21 loci associated with COPD (p<1x10-6) in a published GWAS have at least one shared causal variant between the GWAS and sQTL studies. Among the genes identified to have splice sites associated with top GWAS SNPs was FBXO38, in which a novel exon was discovered to be protective against COPD. Importantly, the sQTL in this locus was validated by qPCR in both blood and lung tissue, demonstrating that splice variants relevant to lung tissue can be identified in blood. Other identified genes included CDK11A and SULT1A2. Overall, these data indicate that analysis of alternative splicing can provide novel insights into disease mechanisms. In particular, we demonstrated that SNPs in a known COPD GWAS locus on chromosome 5q32 influence alternative splicing in the gene FBXO38.While it is known that chronic obstructive pulmonary disease (COPD) is caused in part by genetic factors, few studies have identified specific causative genes. Genetic variants that alter the expression levels of genes have explained part of the genetic component of COPD, however, there are additional genetic variants with unknown function. In some genes the protein coding sequence can be altered by a mechanism known as RNA splicing. We hypothesized that some genetic variants that are associated with risk of COPD contribute to the disease by altering RNA splicing. In this study, we identified genetic variants that are associated both with COPD risk and RNA splicing. In particular, we found that a COPD associated variant of previously unknown function may contribute to the inclusion of a new exon in the FBXO38 gene. These finding are significant because they indicate that analysis of RNA splicing can help identify genes that contribute to disease.

Identification of Functional Variants in the FAM13A Chronic Obstructive Pulmonary Disease Genome Wide Association Study Locus by Massively Parallel Reporter …

Identification of Functional Variants in the FAM13A Chronic Obstructive Pulmonary Disease Genome-Wide Association Study Locus by Massively Parallel Reporter Assays

Chromatin Landscapes of Human Lung Cells Predict Potentially Functional Chronic Obstructive Pulmonary Disease Genome-Wide Association Study Variants

Single Nucleotide Polymorphisms of FAM13A Gene in Chronic Obstructive Pulmonary Disease—A Case Control Study in Vietnam

A Functional Variant Alters Binding of Activating Protein 1 Regulating Expression of FGF7 Gene Associated with Chronic Obstructive Pulmonary Disease

A Genome-Wide Association Study of Chronic Obstructive Pulmonary Disease in Hispanics

Genetic Regulation of Gene Expression in the Lung Identifiescst3andcd22as Potential Causal Genes for Airflow Obstruction

Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations

Association of the FAM 13 A rs 7671167 polymorphism with COPD risk : a meta-analysis

Variants in Multiple Genes Polymorphism Association Analysis of COPD in the Chinese Li Population.

Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies

Novel Common Variants Associated with Body Mass Index and Coronary Artery Disease Detected Using a Pleiotropic Cfdr Method.

Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations

Multi-ancestry Genome-Wide Association Analyses Improve Resolution of Genes and Pathways Influencing Lung Function and Chronic Obstructive Pulmonary Disease Risk

Genome-Wide Association Analysis of Blood Biomarkers in Chronic Obstructive Pulmonary Disease

High-throughput characterization of functional variants highlights heterogeneity and polygenicity underlying lung cancer susceptibility

Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations.

A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene

Integrating Genetics, Transcriptomics, and Proteomics in Lung Tissue to Investigate COPD

Assessing the contribution of rare genetic variants to phenotypes of chronic obstructive pulmonary disease using whole-genome sequence data